Since the widely available COVID-19 vaccine is likely to be permanently close, the initial limitations in supply have left experts wondering: Who gets this vaccine first?
The World Health
Organization (WHO) and its Strategic Advisory Group on Immunization
Specialists, or SEG, have released a plan to distribute the vaccine worldwide -
emphasizing the so-called nationalism of the vaccine. According to the idea
that every country should give priority to its citizens.
Instead, the WHO
influences global practices, prioritizing vaccination among the most vulnerable
people everywhere.
"The first
priority will be to vaccinate some people in all countries, rather than all
people in some countries," said Dr. Tedros Adhanom Ghebreyesus, director
general of the WHO in Geneva on Friday. "Vaccine nationalism will prolong
the epidemic, not shorten it."
The WHO's proposed
vaccine distribution framework ensures that once the novel coronavirus vaccine
is available, it is available. Participants in high- and middle-income
countries, also known as "self-financing", will provide funding for
the Vaccine Accelerator program, summarized as COVAX, knowing that the
long-term goal is global prosperity. ۔
This week, along with
Germany, Japan, Norway and the European Commission, Germany, Japan, Norway and
the European Commission have expressed interest in participating in the CovAX
facility as countries of this financial cooperation. So far, a total of 170
countries plan to participate in the Caucus, representing 70% of the world's
population. The United States is not one of them.
The doctor said,
"The idea behind the coax facility is that the international community
should unite in an enlightened and selfish way to encourage both and then
distribute the vaccine so that there is no country in the world where no one
from the beginning. No vaccine available. “Ruth Faden, PhD, MPH, founder of the
Johns Hopkins Bremen Institute for Bioethics. Countries that finance themselves
are helping the world by helping themselves."
In addition to
strategies for equitable distribution among countries, the WHO framework also
reviews vaccination priorities within each country.
In contrast, last week
a committee that advises U.S. Centers for Disease Control and Prevention
proposed four consecutive steps to prioritize vaccines within the United
States, beginning with health-related health. From caregivers, people with
serious medical conditions and seniors living in crowded facilities.
The WHO guidelines do
not include the order in which specific groups will receive the vaccine, but
the plan highlights some vulnerable groups as a top priority of global impact,
with each country's There is some flexibility based on unique needs.
"We didn't
specifically say who should be the first, second and third group first. It will
come later. Not much time, but it will come later," he added. The
Framework assists in consulting as a group member but does not represent an
international agency.
Faden added that local
delivery patterns, the general volume of vaccine supplies and the country's
infrastructure would affect the distribution strategy. This is likely to change
between now and when a vaccine is approved’ so as more information becomes
available, the Sage Group will begin to prioritize specific groups.
A possible example of a
flexible framework is how children will be considered’ for vaccination.
"There is a lot of
focus in the structure of our values around the negative effects that
epidemics have on the well-being of children - 1.5 billion children are out of
school," Faden said. "It's just amazing, globally, the number of
children whose lives have been affected. The goal is to get children into
school as soon as possible.
"When this vaccine
becomes available, it may be that the first line strategy is to vaccinate
children, not teachers and school staff, just because the data will come first
in adults." "
In the United States,
Pfizer / Biontech recently announced plans to increase testing in 16-year-olds.
"The WHO framework
is particularly noteworthy for its emphasis on global integration with specific
goals for rich countries. ... This framework covers not only the public health
effects of vaccine distribution, but also social And the economic implications
have been considered. "
READ MORE
